Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Drug Therapy × 90 days × Clear all

Phase

Status

Recruiting 62 Not yet recruiting 22 Active not recruiting 20 Completed 7 Terminated 5 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 25 Magnetic Resonance Spectroscopy 16 Biopsy 11 Cyclophosphamide 8 pembrolizumab 4 fludarabine 4 Vincristine 4 Nivolumab 4 Doxorubicin 4 prednylidene 3 durvalumab 3 deltacortene 3 atezolizumab 3 Surveys and Questionnaires 3 Rituximab 3 Radiation 3 Prednisone 3 Lenalidomide 3 Ipilimumab 3 Dexamethasone 3 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 decitabine and cedazuridine drug combination 2 X-Rays 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Mental Status and Dementia Tests 2 Leukapheresis 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡